OsteopetrosisPathogenesis and Rationale for the Use of Interferon-γ-1b

被引:0
|
作者
Lakshmi Shankar
Egbert J. A. Gerritsen
L. Lyndon Key
机构
[1] Medical University of South Carolina,Department of Pediatrics and General Clinical Research Center
[2] Hospital for Sick Children NHS Trust and Institute of Child Health,Department of Immunology
来源
BioDrugs | 1997年 / 7卷
关键词
Bone Resorption; Chronic Granulomatous Disease; Osteopetrosis; Osteoclastic Bone Resorption; Dietary Calcium Intake;
D O I
暂无
中图分类号
学科分类号
摘要
Congenital osteopetrosis is a group of disorders resulting in decreased osteoclastic function and hence decreased bone resorption. Various medical treatments have been attempted to ameliorate the osteopetrotic condition. A calcium-deficient diet has limited further sclerosis in some patients. Prednisone therapy has improved haematological function in some patients, but has not resulted in a reduction in bone mass. Calcitrophic hormones, such as parathyroid hormone (PTH) infusions and oral calcitriol, stimulate osteoclastic activity, and calcitriol in particular has stimulated osteoclastic bone resorption in some patients with osteopetrosis. Bone marrow transplantation, although curative, is limited by paucity of donors, risk of graft-versus-host disease and relapse of the disease.
引用
收藏
页码:23 / 29
页数:6
相关论文
共 50 条
  • [41] Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis
    Trenova, Anastasiya G.
    Slavov, Georgy S.
    Manova, Maria G.
    Kostadinova, Ivanka I.
    ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (06) : 495 - 500
  • [42] Effects of interferon-γ 1b on biomarker expression in patients with idiopathic pulmonary fibrosis
    Strieter, RM
    Starko, KM
    Enelow, RI
    Noth, I
    Valentine, VG
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (02) : 133 - 140
  • [43] Liver and thyroid function and autoimmunity during interferon-β1b treatment for MS
    Durelli, L
    Ferrero, B
    Oggero, A
    Verdun, E
    Ghezzi, A
    Montanari, E
    Zaffaroni, M
    Milanese, C
    NEUROLOGY, 2001, 57 (08) : 1363 - 1370
  • [45] Interferon-β1b Increases Th2 Response in Neuromyelitis Optica
    Nakajima, Hideto
    Hosokawa, Takafumi
    Sugino, Masakazu
    Kimura, Fumiharu
    Hanafusa, Toshiaki
    Takahashi, Toshiyuki
    NEUROLOGY, 2010, 74 (09) : A169 - A169
  • [46] Interferon-β1b in the treatment of secondary progressive MS -: Impact on quality of life
    Freeman, JA
    Thompson, AJ
    Fitzpatrick, R
    Hutchinson, M
    Miltenburger, C
    Beckmann, K
    Dahlke, F
    Kappos, L
    Polman, C
    Pozzilli, C
    NEUROLOGY, 2001, 57 (10) : 1870 - 1875
  • [47] Aktuelle Entwicklungen in der klinischen Interferon-β-1b-ForschungCurrent developments in clinical interferon beta 1b research
    V. Knappertz
    Der Nervenarzt, 2009, 80 (Suppl 1) : 64 - 64
  • [48] Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-β1b
    Jensen, J
    Krakauer, M
    Sellebjerg, F
    CYTOKINE, 2005, 29 (01) : 24 - 30
  • [49] Injecting rationale into interferon-β therapy
    Reder, AT
    Antel, JP
    NEUROLOGY, 2000, 54 (11) : 2034 - 2035
  • [50] Use of an automated injection device for the delivery of interferon β-1b
    Tornatore, C
    Bartlett, D
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S58 - S59